期刊文献+

活动期溃疡性结肠炎与蛋白质和脂质代谢的相关性分析 被引量:4

Correlation between Active Ulcerative Colitis and Protein,Lipid Metabolisms
下载PDF
导出
摘要 背景:溃疡性结肠炎(UC)已成为我国常见的慢性消化系统疾病之一,尽早对疾病活动性和严重度作出准确评估,有助于及时、正确的治疗。目的:分析活动期UC患者蛋白质和脂质代谢指标与疾病活动性和严重度之间的关系。方法:收集2006年1月~2012年11月上海市普陀区中心医院97例活动期UC患者和100名正常对照者,检测总蛋白(TP)、白蛋白(ALB)、球蛋白(GLB)、总胆固醇(TC)、三酰甘油(TG)、载脂蛋白A(ApoA)、载脂蛋白B(ApoB)、脂蛋白a(LPa)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(CDL-C),并分析与疾病活动性、严重度的关系。结果:活动期UC患者BMI、TP、ALB和TC均显著低于正常对照组(P〈0.05)。与轻度活动期UC患者相比,重度和中度活动期UC患者ALB明显降低(P〈0.05),重度活动期TG明显降低(P〈0.05),中度活动期ApoA明显降低(P〈0.05)。相关性分析表明TP与ESR相关(P〈0.05),ALB与ESR、CRP、CAI评分和Baron评分相关(P〈0.05),TC与Baron评分相关(P〈0.05)。结论:活动期UC患者易出现蛋白质和脂质代谢紊乱,TP、ALB、TC与疾病活动性相关;ALB与疾病严重度有关,可作为UC疾病严重度评价的客观指标之一。 Background: Ulcerative colitis (UC) has become one of the commonly seen chronic digestive system diseases in China. Early assessment of activity and severity of UC is helpful for the appropriate treatment. Aims: To analyze the correlation between protein, lipid metabolisms and disease activity, severity in active UC patients. Methods: Ninety-seven UC patients and 100 normal controls from Jan. 2006 to Nov. 2012 at Shanghai Putuo District Central Hospital were enrolled. Total protein (TP), albumin (ALB), globulin (GLB), total cholesterol (TC), triglyceride (TG), apolipoprotein A (ApoA) , apolipoprotein B ( ApoB ) , lipoprotein a (LPa) , high-density lipoprotein cholesterol ( HDL- C), low-density lipoprotein cholesterol (CDL-C) were measured, and their correlations with ESR, CRP, CAI score and Baron score were analyzed. Results: BMI, TP, ALB and TC in active UC patients were significantly lower than those in controls ( P 〈 0.05 ). Compared with mild active UC patients, ALB in severe and moderate active UC patients was significantly decreased ( P 〈 0.05 ) , TG in severe active UC patients and ApoA in moderate active UC patients were significantly decreased ( P 〈 0.05 ). Correlation analysis showed that TP was correlated with ESR ( P 〈 0.05 ), ALB was correlated with ESR, CRP, CAI score and Baron score ( P 〈 0.05 ) , TC was correlated with Baron score ( P 〈 0.05 ). Conclusions: Disorder of protein and lipid metabolisms occur in active UC patients. TP, ALB and TC are associated with disease activity, ALB can be used as an evaluation indicator for the disease severity.
出处 《胃肠病学》 2013年第12期738-740,共3页 Chinese Journal of Gastroenterology
关键词 结肠炎 溃疡性 疾病活动性 疾病严重度 蛋白质代谢 脂质代谢 Colitis, Ulcerative Disease Activity Disease Severity Protein Metabolism Lipid Metabolism
  • 相关文献

参考文献9

  • 1欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见[J].胃肠病学,2007,12(8):488-495. 被引量:751
  • 2Rutgeerts P. Medical therapy of inflammatory bowel disease[J].{H}DIGESTION,1998,(05):453-469.
  • 3谭琰,邹开芳,杨天,陈胜,侯晓华,潘庆华.微生态制剂对溃疡性结肠炎患者治疗前后临床疗效观察[J].中华消化内镜杂志,2008,25(2):77-81. 被引量:50
  • 4Geerling B J,Dagnelie PC,Badart-Smook A. Diet as a risk factor for the development of ulcerative colitis[J].{H}American Journal of Gastroenterology,2000,(04):1008-1013.
  • 5Wagner I J,Rombeau JL. Nutritional support of surgical patients with inflammatory bowel disease[J].{H}Surgical Clinics Of North America,2011,(04):787-803.
  • 6Vermeire S,Van Assche G,Rutgeerts P. Laboratory markers in IBD:useful,magic,or unnecessary toys[J].{H}GUT,2006,(03):426-431.
  • 7Azzolini F,Pagnini C,Camellini L. Proposal of a new clinical index predictive of endoscopic severity in ulcerative colitis[J].{H}Digestive Diseases and Sciences,2005,(02):246-251.
  • 8沈骏,蔡青,冉志华,张尧,周笑甜,殷洪敏,萧树东.活动性炎症性肠病患者蛋白质和脂代谢的变化[J].中华消化杂志,2008,28(5):318-322. 被引量:10
  • 9Ripollés Piquer B,Nazih H,Bourreille A. Altered lipid,apolipoprotein,and lipoprotein profiles in inflammatory bowel disease:consequences on the cholesterol efflux capacity of serum using Fu5AH cell system[J].{H}Metabolism-Clinical and experimental,2006,(07):980-988.

二级参考文献42

  • 1Bibiloni R, Fedorak RN, Tannock GW, et al. VSL#3 probioticmixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol,2005,100 : 1539 -1546.
  • 2Furrie E, Macfarlane S, Kennedy A, et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1 ) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut ,2005,54:242-249.
  • 3Kornbluth A, Sachar DB, Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults (update) : American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol,2004, 99:1371-1385.
  • 4Pullan RD, Rhodes J, Ganesh S,et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med,1994,330:811-815.
  • 5Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis, 2004, 10:286- 299.
  • 6Guarner C, Runyon BA, Young S,et al. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol, 1997,26 : 1372-1378.
  • 7Fiocchi C. Microbial factors in the pathogenesis of IBD. Bioscience Microflora,2003 ,22 :5-14.
  • 8Marteau P, Lepage P, Mangin I, et al. gut flora and inflammatory bowel disease. Aliment Phannacol Ther,2004,20( Suppl 4) : 18- 23.
  • 9Pena AS, Penate M. Genetic susceptibilily and regulation of inflammation in Crohn's disease. Relationship with the innate immune system. Rev Esp Enferm Dig,2002. 94:351- 360.
  • 10MacDermott RP. Alterations in the mucosal immune system in ulcerative colitis and Crohn's disease. Med Clin North Am, 1994,78:1207- 1231.

共引文献802

同被引文献61

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部